OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
OTC: DBLVF 24.07%
Top 5 Canadian Mining Stocks This Week: Adex Mining Shines with 171 Percent Gain
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
OTC: GHVNF 21.76%
Top 5 Canadian Mining Stocks This Week: Euro Manganese Gains 134 Percent
OTC: ACXIF 77.39%
OTC: KORE 77.39%
OTC: NGNE 77.39%
OTC: DBLVF 77.39%
OTC: ONMD 77.39%
